188 related articles for article (PubMed ID: 8140893)
1. Involvement of clathrin light chains in the pathology of Alzheimer's disease.
Nakamura Y; Takeda M; Yoshimi K; Hattori H; Hariguchi S; Kitajima S; Hashimoto S; Nishimura T
Acta Neuropathol; 1994; 87(1):23-31. PubMed ID: 8140893
[TBL] [Abstract][Full Text] [Related]
2. Involvement of clathrin light chains in the pathology of Pick's disease; implication for impairment of axonal transport.
Nakamura Y; Takeda M; Yoshimi K; Hattori H; Hariguchi S; Hashimoto S; Nishimura T
Neurosci Lett; 1994 Oct; 180(1):25-8. PubMed ID: 7533277
[TBL] [Abstract][Full Text] [Related]
3. Association of adipocyte enhancer-binding protein 1 with Alzheimer's disease pathology in human hippocampi.
Shijo M; Honda H; Suzuki SO; Hamasaki H; Hokama M; Abolhassani N; Nakabeppu Y; Ninomiya T; Kitazono T; Iwaki T
Brain Pathol; 2018 Jan; 28(1):58-71. PubMed ID: 27997051
[TBL] [Abstract][Full Text] [Related]
4. Cdk5 and munc-18/p67 co-localization in early stage neurofibrillary tangles-bearing neurons in Alzheimer type dementia brains.
Takahashi M; Iseki E; Kosaka K
J Neurol Sci; 2000 Jan; 172(1):63-9. PubMed ID: 10620662
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of I-kappaB with neurofibrillary pathology in Alzheimer's disease.
Yoshiyama Y; Arai K; Hattori T
Neuroreport; 2001 Aug; 12(12):2641-5. PubMed ID: 11522940
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease: is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology?
Ransmayr G; Cervera P; Hirsch EC; Berger W; Fischer W; Agid Y
Neuroscience; 1992; 47(4):843-51. PubMed ID: 1374541
[TBL] [Abstract][Full Text] [Related]
7. Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins.
Layfield R; Fergusson J; Aitken A; Lowe J; Landon M; Mayer RJ
Neurosci Lett; 1996 May; 209(1):57-60. PubMed ID: 8734909
[TBL] [Abstract][Full Text] [Related]
8. Predominance of clathrin light chain LCb correlates with the presence of a regulated secretory pathway.
Acton SL; Brodsky FM
J Cell Biol; 1990 Oct; 111(4):1419-26. PubMed ID: 2211818
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer's disease.
Namba Y; Tsuchiya H; Ikeda K
Neurosci Lett; 1992 Jan; 134(2):264-6. PubMed ID: 1375354
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to a 100-kd protein reveal abundant A beta-negative plaques throughout gray matter of Alzheimer's disease brains.
Schmidt ML; Lee VM; Forman M; Chiu TS; Trojanowski JQ
Am J Pathol; 1997 Jul; 151(1):69-80. PubMed ID: 9212733
[TBL] [Abstract][Full Text] [Related]
11. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
Papasozomenos SC
Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
Gómez-Ramos P; Morán MA
Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459
[TBL] [Abstract][Full Text] [Related]
13. Structure of human clathrin light chains. Conservation of light chain polymorphism in three mammalian species.
Jackson AP; Parham P
J Biol Chem; 1988 Nov; 263(32):16688-95. PubMed ID: 3267234
[TBL] [Abstract][Full Text] [Related]
14. The second layer neurones of the entorhinal cortex and the perforant path in physiological ageing and Alzheimer's disease.
Moryś J; Sadowski M; Barcikowska M; Maciejewska B; Narkiewicz O
Acta Neurobiol Exp (Wars); 1994; 54(1):47-53. PubMed ID: 8023713
[TBL] [Abstract][Full Text] [Related]
15. Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains.
Ando K; Brion JP; Stygelbout V; Suain V; Authelet M; Dedecker R; Chanut A; Lacor P; Lavaur J; Sazdovitch V; Rogaeva E; Potier MC; Duyckaerts C
Acta Neuropathol; 2013 Jun; 125(6):861-78. PubMed ID: 23589030
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's changes in non-demented and demented patients: a statistical approach to their relationships.
Langui D; Probst A; Ulrich J
Acta Neuropathol; 1995; 89(1):57-62. PubMed ID: 7709732
[TBL] [Abstract][Full Text] [Related]
17. Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology.
Su JH; Zhao M; Anderson AJ; Srinivasan A; Cotman CW
Brain Res; 2001 Apr; 898(2):350-7. PubMed ID: 11306022
[TBL] [Abstract][Full Text] [Related]
18. Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease.
Nakamura Y; Takeda M; Suzuki H; Hattori H; Tada K; Hariguchi S; Hashimoto S; Nishimura T
Neurosci Lett; 1991 Sep; 130(2):195-8. PubMed ID: 1795881
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of 14-3-3 proteins in reactive astrocytes in Creutzfeldt-Jakob disease brains.
Kawamoto Y; Akiguchi I; Jarius C; Budka H
Acta Neuropathol; 2004 Oct; 108(4):302-8. PubMed ID: 15235801
[TBL] [Abstract][Full Text] [Related]
20. Changes in synaptic expression of clathrin assembly protein AP180 in Alzheimer's disease analysed by immunohistochemistry.
Yao PJ; Morsch R; Callahan LM; Coleman PD
Neuroscience; 1999; 94(2):389-94. PubMed ID: 10579202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
